Guanze Medical Information Industry (Holding) Co., Ltd.

SEHK:2427 Stock Report

Market Cap: HK$318.3m

Guanze Medical Information Industry (Holding) Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xianzhen Meng

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentage95.5%
CEO tenure4yrs
CEO ownership73.7%
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

We Think Guanze Medical Information Industry (Holding) (HKG:2427) Can Stay On Top Of Its Debt

Nov 04
We Think Guanze Medical Information Industry (Holding) (HKG:2427) Can Stay On Top Of Its Debt

Here's What's Concerning About Guanze Medical Information Industry (Holding)'s (HKG:2427) Returns On Capital

Sep 10
Here's What's Concerning About Guanze Medical Information Industry (Holding)'s (HKG:2427) Returns On Capital

Guanze Medical Information Industry (Holding) (HKG:2427) Has A Pretty Healthy Balance Sheet

Jun 13
Guanze Medical Information Industry (Holding) (HKG:2427) Has A Pretty Healthy Balance Sheet

Guanze Medical Information Industry (Holding) (HKG:2427) Will Pay A Dividend Of CN¥0.021

Apr 25
Guanze Medical Information Industry (Holding) (HKG:2427) Will Pay A Dividend Of CN¥0.021

Guanze Medical Information Industry (Holding)'s (HKG:2427) Dividend Will Be CN¥0.021

Mar 31
Guanze Medical Information Industry (Holding)'s (HKG:2427) Dividend Will Be CN¥0.021

Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Nov 23
Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Jun 29
Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

There's Reason For Concern Over Guanze Medical Information Industry (Holding) Co., Ltd.'s (HKG:2427) Massive 27% Price Jump

Apr 19
There's Reason For Concern Over Guanze Medical Information Industry (Holding) Co., Ltd.'s (HKG:2427) Massive 27% Price Jump

CEO Compensation Analysis

How has Xianzhen Meng's remuneration changed compared to Guanze Medical Information Industry (Holding)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥11m

Mar 31 2024n/an/a

CN¥20m

Dec 31 2023CN¥1mCN¥1m

CN¥28m

Sep 30 2023n/an/a

CN¥23m

Jun 30 2023n/an/a

CN¥19m

Mar 31 2023n/an/a

CN¥18m

Dec 31 2022CN¥161kCN¥120k

CN¥18m

Sep 30 2022n/an/a

CN¥23m

Jun 30 2022n/an/a

CN¥27m

Mar 31 2022n/an/a

CN¥25m

Dec 31 2021CN¥120kCN¥120k

CN¥23m

Dec 31 2020CN¥120kCN¥120k

CN¥29m

Dec 31 2019CN¥120kCN¥120k

CN¥22m

Compensation vs Market: Xianzhen's total compensation ($USD172.78K) is about average for companies of similar size in the Hong Kong market ($USD230.88K).

Compensation vs Earnings: Xianzhen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Xianzhen Meng (54 yo)

4yrs

Tenure

CN¥1,261,000

Compensation

Mr. Xianzhen Meng is CEO & Chairman of Guanze Medical Information Industry (Holding) Co., Ltd. Meng was appointed as a Director of Guanze Medical Information Industry (Holding) Co., Ltd. on 11 December 20...

Board Members

NamePositionTenureCompensationOwnership
Xianzhen Meng
CEO & Chairman4yrsCN¥1.26m73.74%
HK$ 234.7m
Zhenyu Guo
Chief Sales Officer & Executive Director3.3yrsCN¥274.00kno data
Man Hin Wong
Independent Non-Executive Director2yrsno datano data
Qingyang Meng
Non-Executive Director3.3yrsCN¥109.00kno data
Bin Zhao
Independent Non-Executive Director2yrsno datano data
Shiwang Chang
Independent Non-Executive Director2yrsno datano data

2.6yrs

Average Tenure

50yo

Average Age

Experienced Board: 2427's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 22:14
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guanze Medical Information Industry (Holding) Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution